It's a great grift, too. @Regenexx had convinced the gullible that its treatments will keep employees from needing expensive joint replacement surgery. They won't. 2/
-
-
Show this thread
-
What will happen is either: 1. The stem cells won't work, and the employee will need the surgery anyway. 2. The stem cells won't work, and their plan won't pay for the surgery they need. Either way, employees with degenerative joint disease are screwed. 3/3
Show this thread
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.